Schall Thomas J.

Avg. Two Year Performance

No purchase track record
(45%) Avg. Sale Return
(20%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)(8%)(15%)(32%)(45%)
Sale Success Rate19 of 2416 of 2414 of 2413 of 2412 of 24
Drugs » Biotechnology

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--